Key result
Tumor resection and chemotherapy for primary cardiac angiosarcoma in a 37-year-old pregnant woman resulted in tumor recurrence 11 months after surgery.
Why the study?
Cardiac angiosarcoma is a rare, highly malignant cardiac tumor with poor prognosis, and current treatment approaches are not effective.
Case Report (n=1)
Primary cardiac angiosarcoma is highly malignant and can recur rapidly despite surgical resection and chemotherapy, highlighting the need for comprehensive multimodality treatment.
Answers are grounded in this paper and cite their sources.
Supports aggressive biology of cardiac angiosarcoma despite resection and chemotherapy; leaves open optimal multimodality strategies.
BACKGROUND: Cardiac angiosarcoma is a rare but highly malignant cardiac tumor. It is characterized by poor prognosis, and current treatment approaches are not effective. CASE PRESENTATION: A 37-year-old female with 35 weeks pregnancy experienced chest tightness and shortness of breath for 1 month. She was diagnosed with primary cardiac angiosarcoma. Delivery of fetus was performed early to treat the mother. The patient underwent resection of the tumor then she was treated with chemotherapy. However, the tumor recurred 11 months after surgery. CONCLUSION: Angiosarcoma is a highly malignant tumor explaining recurrence of the tumor recurred after surgery. Cardiac angiosarcoma should be treated through a comprehensive treatment plan, comprising surgery, radiotherapy, and chemotherapy approaches.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) conducted a case report in Primary cardiac angiosarcoma (n=1). Tumor resection and chemotherapy was evaluated on Tumor recurrence. Tumor resection and chemotherapy for primary cardiac angiosarcoma in a 37-year-old pregnant woman resulted in tumor recurrence 11 months after surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: